Manager TitleAgeSince
Chief Executive Officer 49 30/05/2025
Director of Finance/CFO 61 30/05/2025
Sales & Marketing 53 31/12/2023
Director TitleAgeSince
Director/Board Member 62 31/12/2019
Chairman 42 31/05/2025
Director/Board Member 75 31/05/2025
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
+1.34%+3.94%-15.85%-1.38% 183B
+1.51%+4.17%-2.98%+1.43% 109B
-0.95%-0.49%+6.94%+61.09% 60.57B
+2.37%+2.85%+44.34%+56.22% 51.8B
+2.77%+8.86%-3.49%-38.38% 45.64B
+3.03%+4.44% - - 33.22B
+4.63%+22.04%+10.13%-29.48% 31.49B
+2.05%+6.01%+45.42%-6.11% 24B
+1.86%+8.67%+2.54%+2.12% 22.26B
Average -1.82%+4.52%+10.88%+5.69% 62.35B
Weighted average by Cap. +1.12%+3.37%+1.52%+7.08%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock